| Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients (NCT04835883) | Hanyang University Seoul Hospital | 2019-09-26 |
| Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial (NCT04077684) | Peking University People's Hospital | 2019-09-10 |
| A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) (NCT03843125) | Eli Lilly and Company | 2019-09-09 |
| Effect of Curcumin on Systemic Lupus Erythematosus (NCT03953261) | Loma Linda University | 2019-09-01 |
| Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus (NCT03951259) | RenJi Hospital | 2019-07-24 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Autophagy in Systemic Lupus Erythematosus (NCT03583853) | Assiut University | 2019-07-01 |
| Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells (NCT04184258) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2019-07-01 |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease (NCT03656627) | Alliance Foundation Trials, LLC. | 2019-06-27 |
| Addressing Disparities in Lupus Care Through an Integrated Care Management Program (NCT03915652) | Brigham and Women's Hospital | 2019-06-21 |
| Cell Surface Marker Expression in Autoimmune Diseases (NCT03757065) | Alpine Immune Sciences, Inc. | 2019-06-12 |
| Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus (NCT03804723) | University of Pisa | 2019-06-01 |
| Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases (NCT03937856) | Johns Hopkins University | 2019-05-07 |
| Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects (NCT03949426) | Kangpu Biopharmaceuticals, Ltd. | 2019-05-01 |
| A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (NCT03845517) | Pfizer | 2019-04-18 |
| Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome (NCT03937271) | Taipei Veterans General Hospital, Taiwan | 2019-04-01 |
| Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus (NCT03920267) | Bristol-Myers Squibb | 2019-03-26 |
| Laser Therapy for Patients With Systemic Lupus Erythematosus (NCT04453215) | Dr. Merve Benli | 2019-01-12 |
| LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE (NCT04141046) | University of North Carolina, Chapel Hill | 2019-01-01 |
| Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus (NCT03742037) | Viatris Innovation GmbH | 2018-12-21 |
| Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus (NCT03618056) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-19 |
| Implementing the Decision-Aid for Lupus (IDEAL Strategy) (NCT03735238) | University of Alabama at Birmingham | 2018-12-15 |
| A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis (NCT03817424) | Amgen | 2018-12-13 |
| Tissue Sodium in Autoimmune Disease (NCT02525835) | Vanderbilt University | 2018-12-01 |
| Fatigue, Depression, and Cortical Excitability in Systemic Lupus (NCT03165682) | Assiut University | 2018-12-01 |
| Peer Approaches to Lupus Self-management (NCT03734055) | Medical University of South Carolina | 2018-11-30 |
| Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) (NCT03878303) | ACEA Therapeutics, Inc. | 2018-11-28 |
| Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis (NCT03575156) | University Hospital, Bordeaux | 2018-09-20 |
| A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (NCT03616912) | Eli Lilly and Company | 2018-08-02 |
| A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) (NCT03616964) | Eli Lilly and Company | 2018-08-02 |
| An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects (NCT03541564) | Bristol-Myers Squibb | 2018-05-30 |
| Hydroxychloroquine in Systemic Lupus Erythematosus (NCT03802188) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2018-05-09 |
| A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) (NCT03556007) | Nektar Therapeutics | 2018-04-18 |
| Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE (NCT03537638) | Servicio Canario de Salud | 2018-04-16 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus (NCT03451422) | Amgen | 2018-04-10 |
| Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus (NCT03179046) | Assiut University | 2018-04-01 |
| Systemic Lupus Erythematosus Exercise Program (NCT03942718) | University Medical Center Mainz | 2018-03-21 |
| Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology (NCT03459274) | Cedars-Sinai Medical Center | 2018-03-16 |
| Monitoring the IMmUological TOXicity of Drugs (NCT03480529) | Groupe Hospitalier Pitie-Salpetriere | 2018-03-01 |
| Exploratory Study of DHA in Systemic Lupus Erythematosus Patients (NCT03396393) | Kunming Pharmaceuticals, Inc. | 2018-03-01 |
| A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE (NCT03312907) | GlaxoSmithKline | 2018-03-01 |
| Neutrophil Extracellular Traps in Systemic Sclerosis (NCT03374618) | CHU de Reims | 2018-02-23 |
| Aerobic Exercise in Women With Systemic Lupus Erythematosus (NCT03186794) | National Institutes of Health Clinical Center (CC) | 2018-02-22 |
| A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (NCT03393013) | Kezar Life Sciences, Inc. | 2018-02-20 |
| BENLYSTA® Special Drug Use Investigation (NCT03370263) | GlaxoSmithKline | 2018-01-15 |
| Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care (NCT03371251) | Boston Pharmaceuticals | 2018-01-10 |
| Treatment and Clinical Outcomes Among SLE Patients in Pregnancy (NCT04976465) | Qilu Hospital of Shandong University | 2018-01-01 |
| Maternal Autoimmune Disease Research Alliance (MADRA) Registry (NCT03276923) | Duke University | 2018-01-01 |
| Care Coordination Approaches to Learning Lupus Self-management (NCT04400240) | Medical University of South Carolina | 2018-01-01 |
| Study of Anti-Malarials in Incomplete Lupus Erythematosus (NCT03030118) | Milton S. Hershey Medical Center | 2017-12-28 |
| JBT-101 in Systemic Lupus Erythematosus (SLE) (NCT03093402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-12-21 |
| Study During Pregnancy of Expression of miRNAs in RA or SLE (NCT02350491) | University Hospital, Strasbourg, France | 2017-12-17 |
| Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis (NCT03334851) | Pfizer | 2017-11-17 |
| An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus (NCT03252587) | Bristol-Myers Squibb | 2017-09-21 |
| A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation (NCT03254784) | Bristol-Myers Squibb | 2017-09-13 |
| The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients (NCT03262727) | Bristol-Myers Squibb | 2017-09-01 |
| Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus (NCT03288324) | Children's Hospital Medical Center, Cincinnati | 2017-08-23 |
| Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus (NCT03142711) | Lupus Research Alliance | 2017-08-21 |
| Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) (NCT03446339) | The University of Hong Kong | 2017-08-03 |
| Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus (NCT03219801) | Hebei Medical University | 2017-08-01 |
| A Phase I Study of ICP-022 in Healthy Subjects (NCT03189017) | Innocare Pharma Australia Pty Ltd | 2017-07-03 |
| Accuracy, Feasibility and Acceptance of CGM Lupus (NCT03296995) | RenJi Hospital | 2017-07-01 |
| Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) (NCT03189875) | AstraZeneca | 2017-06-28 |
| Regulatory BCells in Systemic Lupus Erythematosus (NCT03178721) | Assiut University | 2017-06-25 |
| Clinical Performance of BioCLIA Ro60 (NCT03204448) | HOB Biotech Group | 2017-05-08 |
| Systemic Lupus and Adverse Pregnancy Outcome (NCT03171103) | Beni-Suef University | 2017-05-01 |
| Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization (NCT03142412) | DxTerity Diagnostics | 2017-04-17 |
| Exercise and Arterial Stiffness in Systemic Lupus Erythematosus (NCT03107442) | Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental | 2017-04-12 |
| A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations (NCT02962960) | AstraZeneca | 2017-02-14 |
| Scrutinizing the Heterogeneity of SLE: Defining Phenotypes (NCT03348774) | University Health Network, Toronto | 2017-02-09 |
| Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus (NCT02880852) | GlaxoSmithKline | 2017-01-23 |
| A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus (NCT02908100) | Genentech, Inc. | 2017-01-19 |
| ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) (NCT02955615) | Iltoo Pharma | 2017-01-18 |
| A Phase II Study of M2951 in SLE (NCT02975336) | EMD Serono Research & Development Institute, Inc. | 2017-01-04 |
| OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis (NCT02554474) | University of British Columbia | 2017-01-01 |
| Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) (NCT02847598) | Biogen | 2016-10-20 |
| Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus (NCT02842814) | Peking Union Medical College Hospital | 2016-10-01 |
| The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients (NCT03802578) | National and Kapodistrian University of Athens | 2016-09-28 |
| CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis (NCT02514967) | Anthera Pharmaceuticals | 2016-06-01 |
| The Effect of Metformin on Reducing Lupus Flares (NCT02741960) | RenJi Hospital | 2016-05-24 |
| Anti-infection of Low-does IL-2 in SLE (NCT02932137) | Peking University People's Hospital | 2016-05-05 |
| Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients (NCT02331810) | Sanofi | 2016-04-01 |
| Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE (NCT02769195) | Monash University | 2016-04-01 |
| Single Ascending Dose Study of AMG 570 in Healthy Subjects (NCT02618967) | Amgen | 2016-03-28 |
| A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) (NCT02708095) | Eli Lilly and Company | 2016-03-24 |
| Walk With Ease Program For Patients With Systemic Lupus Erythematosus (NCT02631005) | University of North Carolina, Chapel Hill | 2016-03-01 |
| A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus (NCT02725515) | Xencor, Inc. | 2016-02-16 |
| Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases (NCT02925351) | Jonsson Comprehensive Cancer Center | 2016-01-25 |
| Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) (NCT02885610) | RemeGen Co., Ltd. | 2015-12-01 |
| A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus (NCT02609789) | Janssen Research & Development, LLC | 2015-12-01 |
| CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis (NCT02074020) | Anthera Pharmaceuticals | 2015-12-01 |
| Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome (NCT02741362) | Arkansas Heart Hospital | 2015-12-01 |
| Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus (NCT02917265) | Aikaterini Thanou | 2015-11-01 |
| Safety and Immunogenicity of a Zoster Vaccine in SLE (NCT02477150) | Tuen Mun Hospital | 2015-11-01 |
| Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus (NCT02554019) | Biotest | 2015-09-28 |
| Phase IIb Study of IFN-K in Systemic Lupus Erythematosus (NCT02665364) | Neovacs | 2015-09-23 |
| Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus (NCT02535689) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2015-08-28 |
| Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus (NCT02533570) | Seagen Inc. | 2015-07-01 |
| Long-term Immunogenicity of a HPV Vaccine in SLE (NCT02477254) | Tuen Mun Hospital | 2015-07-01 |
| Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) (NCT02338999) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2015-06-18 |